A blood and marrow transplant offers hope for patients with hematologic and lymphatic cancers

Blood and marrow transplants are among the most effective treatments for certain hematologic and lymphatic cancers.

At Baylor Scott & White Health, our blood and bone marrow transplant process and programs offer new hope for patients dealing with life-threatening cancers.

When is a blood and marrow transplant appropriate?

Thanks to advances such as reduced-intensity transplants, haploidentical transplants and related/unrelated donor transplants, a blood and marrow transplant (BMT) is available to more people than ever. Increased survival rates have gone hand-in-hand with innovative treatment approaches.

Today, BMT is often the treatment option of choice for patients diagnosed with:

image https://bswh-p-001-delivery.sitecorecontenthub.cloud/api/public/content/b97a0db0380b481bbe1ff68f1cd9e779?v=b450e041

Immune effector cell therapy

For the past 30 years, adoptive cellular therapy with immune effector cells including a variety of lymphocytes, has been developed at research centers around the world.

Chimeric antigen receptor CAR T-cell have emerged from the lab as FDA-approved treatments for a variety of cancers. This includes some gene-modified T cells and natural (NK) cells. The future for effector cell therapy is bright, as it becomes the treatment of choice for many cancer patients. Baylor Scott & White Health will continue to play a leading role in these pioneering efforts.

Contact our patient nurse navigators at 214.820.3535 for more information about CAR T and immune effector cell therapies and clinical trials.

Learn more about CAR T-cell therapy

image https://bswh-p-001.sitecorecontenthub.cloud/api/public/content/9b2963e557e54f3fa5c13c10b5af2783?v=e72c83e8

Blood and marrow transplant options

The blood and marrow physician specialist will recommend a specific type of blood and marrow transplant after considering individual patient factors.

What to expect

From start to finish, the transplant generally takes a few months.

  • Stem cells are harvested (collected) from bone marrow for a BMT transplant
    • A donor or the transplant patient him or herself can serve as the source for the bone marrow stem cells.
  • Depending on the care plan devised by our team of specialists, the transplant patient will receive chemotherapy, radiation therapy or a combination of both, to kill her or his cancer cells, immune system, or both.
  • The stem cells are infused (injected) into the patient’s bloodstream where they begin to produce healthy stem cells and bone marrow.
image https://bswh-p-001-delivery.sitecorecontenthub.cloud/api/public/content/4a7a08fe9e7d4f1085b2e1528e85043e?v=e89e0a04

National Marrow Donor Program

The National Marrow Donor Program (NMDP) was started in 1986 to serve as a national database of tissue types from individuals willing to donate marrow to patients needing a marrow transplant.

Since that time, the registry, now called the Be The Match® Registry, has over 8 million individuals registered.

It is linked with registries all over the world, making it an international registry to serve any patient needing a transplant anywhere in the world.